Active vitamin D metabolites in glucocorticoid-induced osteoporosis (Q73067497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Active vitamin D metabolites in glucocorticoid-induced osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

glucocorticoid-induced osteoporosis

1 November 2019

main subject

1 reference

J D Ringe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

Calcified Tissue International

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

124-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030494%20AND%20SRC:MED&resulttype=core&format=json

Corticosteroid osteoporosis

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Generalised bone loss in patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Bone loss in patients with inflammatory bowel disease: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

What is the future for fluoride in the treatment of osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Cyclical edidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Generalized osteoporosis in non-steroid treated rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

1,25-Dihydroxyvitamin D3 Corrects Bone Loss But Suppresses Bone Remodeling in Ovariohysterectomized Beagle Dogs*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200

Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002239900200